AURKA and neoplasm: In all, 1-year and 2-year survival were also longer among patients with high AURKA-CN tumours compared with those with low AURKA-CN tumours (1 year: 92.5% vs 82.2% P<0.001; 2 year: 80.9% vs 29.9%, P<0.001).